Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin for treating depression
IRCT201304203930N22Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lovastatin in major depressive disorder (MDD) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Apr 2013; status: completed.
02
Drugs
lovastatin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT201304203930N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201304203930N22.